Cognitive Training for Mild Cognitive Impairment
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new program aimed at improving thinking and mental health in older adults with mild memory and cognitive challenges. The study tests a new version of a cognitive training method that considers the impact of stress related to race and discrimination. Participants will be divided into two groups: one will try the new program, Race Based Stress and Empowerment Focused Compensatory Cognitive Training for Mild Cognitive Impairment (RBSEF-CCT-MCI), while the other will use the original version, Motivationally Enhanced Compensatory Cognitive Training for Mild Cognitive Impairment (ME-CCT). Individuals who self-identify as Black/African American and experience mild memory issues are well-suited for this trial. As an unphased trial, this study provides participants the opportunity to contribute to innovative research that could lead to improved cognitive health strategies.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.
What prior data suggests that this cognitive training is safe for individuals with mild cognitive impairment?
Research has shown that the Motivationally Enhanced Compensatory Cognitive Training (ME-CCT) program, which forms the basis for the new RBSEF-CCT-MCI treatment, has been used safely in previous studies. This program includes exercises to improve thinking and memory skills. Participants in past trials generally tolerated it well, with no major safety issues reported.
The new version, RBSEF-CCT-MCI, focuses on race-related stress and empowerment. Although this specific version is new, its components have been tested for safety in other studies. These studies have demonstrated that addressing stress and empowerment can be safe and helpful.
This study is in the "Not Applicable" phase, meaning the main goal is to assess the treatment's effectiveness, not its safety. Earlier research suggests the treatment is expected to be safe. However, as with any clinical trial, researchers will closely monitor participants for any unexpected effects.12345Why are researchers excited about this trial?
Researchers are excited about Race Based Stress and Empowerment Focused Compensatory Cognitive Training for Mild Cognitive Impairment (RBSEF-CCT-MCI) because it introduces a novel approach to tackling mild cognitive impairment (MCI). Unlike traditional treatments that often focus on medications or generalized cognitive exercises, RBSEF-CCT-MCI specifically addresses the unique stressors faced by individuals due to racial experiences, aiming to empower participants while enhancing cognitive function. This tailored approach not only targets cognitive deficits but also considers emotional and social factors, which could lead to more effective and personalized outcomes for those affected by MCI.
What evidence suggests that this trial's treatments could be effective for mild cognitive impairment?
Research has shown that addressing race-related stress can enhance coping mechanisms and improve mental well-being. A previous small study found that a similar method, called RiSE, helped African American women manage racism and adopt healthy coping strategies. In this trial, participants in the experimental arm will receive the new RBSEF-CCT-MCI treatment, which combines mental exercises with addressing race-related stress. This dual approach aims to enhance both mental health and cognitive skills, such as memory, for those with mild cognitive impairment. While researchers are still gathering direct evidence for RBSEF-CCT-MCI, its components have shown promise in related areas. Meanwhile, participants in the control group will complete the original ME-CCT training program.12356
Who Is on the Research Team?
Rachael L Ellison, PhD
Principal Investigator
Rosalind Franklin University of Medicine and Science
Are You a Good Fit for This Trial?
This trial is for older adults with mild cognitive impairment (MCI), particularly those from racial minority groups who may experience race-based stress and discrimination. Participants should be interested in group-based interventions aimed at improving cognitive functioning and mental health.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pilot Intervention
Participants receive group-based intervention for 8 weeks focusing on race-based stress and cognitive training
Randomized Controlled Trial (RCT)
Participants are randomized to either the active control group (ME-CCT) or the experimental group (RBSEF-CCT-MCI) for 8 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Motivationally Enhanced Compensatory Cognitive Training for Mild Cognitive Impairment (ME-CCT)
- Race Based Stress and Empowerment Focused Compensatory Cognitive Training for Mild Cognitive Impairment (RBSEF-CCT-MCI)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rosalind Franklin University of Medicine and Science
Lead Sponsor